403 related articles for article (PubMed ID: 20489416)
41. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
42. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
43. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
Wierzbicki AS
Diabetes Obes Metab; 2009 Mar; 11(3):261-70. PubMed ID: 17645560
[TBL] [Abstract][Full Text] [Related]
44. Dyslipidaemia in diabetic patients: time for a rethink.
Shepherd J
Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
[TBL] [Abstract][Full Text] [Related]
45. Role for fibrate therapy in diabetes: evidence before FIELD.
Vergès B
Curr Opin Lipidol; 2005 Dec; 16(6):648-51. PubMed ID: 16276243
[TBL] [Abstract][Full Text] [Related]
46. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
47. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
48. Management of lipids in the prevention of cardiovascular events.
Glassberg H; Rader DJ
Annu Rev Med; 2008; 59():79-94. PubMed ID: 17937591
[TBL] [Abstract][Full Text] [Related]
49. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?
Shah PK
Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083
[TBL] [Abstract][Full Text] [Related]
50. [Lipid management--treatment goal and strategy].
Koshiyama H
Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.
Liberopoulos E; Vlasserou F; Mitrogianni Z; Papageorgantas I; Elisaf M;
Angiology; 2012 Apr; 63(3):184-93. PubMed ID: 21676964
[TBL] [Abstract][Full Text] [Related]
52. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M; Jialal I
Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
[No Abstract] [Full Text] [Related]
53. Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.
Ardigò D; Vaccaro O; Cavalot F; Rivellese AA; Franzini L; Miccoli R; Patti L; Boemi M; Trovati M; Zavaroni I;
Eur J Prev Cardiol; 2014 Apr; 21(4):456-63. PubMed ID: 23147277
[TBL] [Abstract][Full Text] [Related]
54. What to make of ACCORD. Surprising new results from the landmark diabetes study.
Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):1-2, 7. PubMed ID: 20848750
[No Abstract] [Full Text] [Related]
55. Combination lipid therapy in type 2 diabetes mellitus.
Vergès B
Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
[TBL] [Abstract][Full Text] [Related]
56. Transient dyslipidemia mimicking the plasma lipid profile of Tangier disease in a diabetic patient with gram negative sepsis.
Palacio C; Alexandraki I; Bertholf RL; Mooradian AD
Ann Clin Lab Sci; 2011; 41(2):150-3. PubMed ID: 21844573
[TBL] [Abstract][Full Text] [Related]
57. [Not Available].
Bilz S
Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
[No Abstract] [Full Text] [Related]
58. Therapies for diabetic dyslipidaemia.
Bell DS; Al Badarin F; O'Keefe JH
Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
[TBL] [Abstract][Full Text] [Related]
59. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
[TBL] [Abstract][Full Text] [Related]
60. High-density lipoprotein cholesterol and triglycerides in the statin era: a pending issue?
Paillard F
Arch Cardiovasc Dis; 2009 Mar; 102(3):165-7. PubMed ID: 19375669
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
